{"name":"Kyverna Therapeutics","slug":"kyverna-therapeutics","ticker":"","exchange":"","domain":"kyverna.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOVnZ2eG1nOVFOMUFmWElrSTRiNzV0aUctcTJJN2lXUEpDLXpPMVZlQ2hjdlVCalVPWVZERnl2enV0aXpJc3hhZFA0UklFY3RhdkdtWTAxUHA1RjZ6TzRwT01HeHB4bXRQVDA4UmJSblBBdENseTBMcXpRV0lDMkNyTUM4M3M5N1pLcnNOYUJ6RzUxQ1F0cXFQaXVRd0Vrdk9XbUROSXhORm4?oc=5","date":"2026-03-03","type":"pipeline","source":"Seeking Alpha","summary":"Kyverna Therapeutics: The King Of The CAR-T Autoimmune Revolution - Seeking Alpha","headline":"Kyverna Therapeutics: The King Of The CAR-T Autoimmune Revolution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOaDJKblJ2Y3MycEM5LWt1cm5QWXBkSllland2eVZ5OUp6ZFdRdjVEWWJXakd5a0VlellzZlZYUmJvQXpYMy00XzE2aW8wOGRDSWlVcHp2LW5FdnhkYmI3S1JzWHNrNlBSNTNKZ1lSRHV5NUI3S0o1MFVibl90WWUtaXpJWGRTeWdxTVVMYTllZGZIOHJ0NllqWGhudmo4SmlpMDVSXzdlUFVPXzZ1QkwxdFAxXzdNRU0?oc=5","date":"2026-02-16","type":"pipeline","source":"24/7 Wall St.","summary":"Wall Street Thinks These 4 Biotech Stocks Will Double--At Least--This Year - 24/7 Wall St.","headline":"Wall Street Thinks These 4 Biotech Stocks Will Double--At Least--This Year - 24/7 Wall St.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOYlFZaGs1RUlsSDhxSWtXVlBUcE12LXk4OHVrLTV6em9KU0JEeDluQzhQcDF3SEV3djVzc2d4bDhnM0VfRE1LTEdQNnI3VVE5elZfRU5SOTNCSHVJOFJtM0VDczJhanhjZWludl94dVAtQVRwc2htaWpGZ192SlZzdHhGRWNKQVNIamdCRzJ3a2tpVmhkSU51UHIwS0RkazctaEVvV1BPcGlCbFFxdHY4N0hNVUota1FNSUwxRzEySDVaTDY5amtiNw?oc=5","date":"2025-12-15","type":"trial","source":"Fierce Biotech","summary":"'Unprecedented' data prime Kyverna for 1st autoimmune CAR-T drug - Fierce Biotech","headline":"'Unprecedented' data prime Kyverna for 1st autoimmune CAR-T drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPaldEMFFFMzVOV3IzU09vR2piOTJ6Q0pVdjFPNm9fa3FMakxVQ3FOY3ZZcXNnNWhRYUVXdjBvS3NpR2tuQ1dab3BUMFp5ZlpjRzVzaGNkUFdSMEtGdTIxUVVYWlUtTmNGOHpxbVVJbkN3eFNfNzZaZ0JSXzF6S00wT01JSjlMQ3otRl9GNnFDWVVzbm44RVZRU29MZEhBb0lIRUtWc25Ucw?oc=5","date":"2025-12-15","type":"pipeline","source":"BioPharma Dive","summary":"Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease - BioPharma Dive","headline":"Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBEWlNJTVZYaGMyMVZKTGNsaXRmSl96WXczV1otQl9YZW0talhpb3g5NGlxMVpyRm9JU1ViRVVpcWJSSmN0a2NTTXI4bmdPNWhiRVhHWUE0dXJxYWpXeUdMXzZvQzJCMWlLRExpR1dVZ1BlQ0ZXbzBUaUtB?oc=5","date":"2025-12-15","type":"trial","source":"pharmaphorum","summary":"Kyverna rises on stiff person syndrome data - pharmaphorum","headline":"Kyverna rises on stiff person syndrome data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBIV2RQa201MmVvN1Z2aGdaZ3I0MTl1UkRJcTMybkxRaGlSYTduNk9pNkgyVU0tM1hYQktJNFB3QVhpY1ExSjBEWElleW1Xbmtzak53?oc=5","date":"2025-12-15","type":"trial","source":"FirstWord Pharma","summary":"Kyverna shares spike as CAR-T hits endpoints in stiff person syndrome - FirstWord Pharma","headline":"Kyverna shares spike as CAR-T hits endpoints in stiff person syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNNENVVjl4NUJGMEs0UTJ0UXB5U1FvczRlTmFrWEREOXNvT0g5QTVsVGpnQU91VERsZ0FWUUM3WmEzd2ljYy1YUW52eFI0Q3JkaHpfR3RidktROU5uOFJkOUp5MWVSSV8yOS1ZV1F5YjRiT2liS3NTWkxYQ2Zra2tHWlRqcw?oc=5","date":"2025-12-15","type":"pipeline","source":"stockstotrade.com","summary":"Can Kyverna Therapeutics Stock Surge Further? - stockstotrade.com","headline":"Can Kyverna Therapeutics Stock Surge Further?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQRThoSE5oRWpsQzdDVEZrZEhHR0d0TnZwYXZNM3NhYkVzLVR4SWlYcXprQUVxd1EyTDdWSVljY2h1SGgyN0F4czFQbFBabk0wSUFDeWNPR2N6d2pUM3ZiVzJxbU11VXZpbENKbXZZVWtSV3o3clZZemFTb0JzTFljM2lkMDcyRXc?oc=5","date":"2025-12-01","type":"pipeline","source":"BioSpace","summary":"6 Companies Hanging On in Cell Therapy - BioSpace","headline":"6 Companies Hanging On in Cell Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNOUs2RnhPaDFGMjBCdnJaTTVTZ2dtSXhLUy1yNTU1S2NiTjQ1c1JoLTV5WVZqR3FnbGFiay1mcDdnTjdMNWstRWwzWDFJcS1tSDE0aFFSaUNNMC1WQjdyTkNLeXI5RmFUNUctd2toLWQ0Z3djT0JEZW5qbldqVTM5dGhOVTVVekF2aE9EVXNIZkF6NHNHQnVEZ0xIU1VyNVNNTEljZU5RTWFEWC1JdDhWQjhzSQ?oc=5","date":"2025-09-03","type":"trial","source":"Streetwise Reports","summary":"Cell Therapy Firm Kyverna Advances U.S. Phase 3 MG Trial - Streetwise Reports","headline":"Cell Therapy Firm Kyverna Advances U.S. Phase 3 MG Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOcUcxNjZLMEtYUW5YME42b2x1LUJWVVN6UnFpQ3B1YUdvd1VDdmcxRlQ5bDhZOXpJRXB2ejRZWGd3cHV6VHhEY3ItdGY5RENkV1Z4Tk13dEtiTXRNMWZVdzRSY0htMFlLS3hfUXBwdzRMT0RKdFF4aFJ0QmwtRF9fUTdCNktJVEVsVUdsMnJyWHo?oc=5","date":"2025-08-21","type":"deal","source":"BioPharma Dive","summary":"Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius - BioPharma Dive","headline":"Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1fQUpnWUVrU2VaYlhweUlPNkNzQ1lKZVZxUW41aUZCMzZfbktHV0JIWHA1N2tYZmxreGJaRXY5UGszNE5NcVdPUjU2V1VwWk9mb1Yw?oc=5","date":"2025-05-14","type":"pipeline","source":"FirstWord Pharma","summary":"Layoffs hit CAR-T developers Allogene, Kyverna - FirstWord Pharma","headline":"Layoffs hit CAR-T developers Allogene, Kyverna","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNSmVBR29iX3lhQ1plUnJMa2pGLVVkNFd4SGxPVG0tWGE0RXlqTXYyNl9MOXg5OFg5X2IwRk00aWZDQlhObG1pbGlOdTNqVVBTUHYzb1RZZHZZTTVieEpkclJIVWRVbkRwZV9LVVdTNmpQQjNIOWhIMVBPMGdvZ0VUSERfZFdTVFdmbnRFbFBQU1VadXZFTFRrS2VHenNVdTZyeUZHenZsWEhzblpVQVhpNlJSQW9HbmhNLVlDZXlkUlllQjZPQ195OWZsWkVKVG1leElQaVNB?oc=5","date":"2024-12-13","type":"trial","source":"PR Newswire","summary":"Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth - PR Newswire","headline":"Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}